BNTX BNTX

BioNTech Share Price

162.48
2.13 (1.33%)
Upgrade to Real-Time
Afterhours (Closed)
162.48
Volume 608,803
Bid Price 162.35
Ask Price 163.05
News -
Company Name Stock Ticker Symbol Market Type
BioNTech SE BNTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
2.13 1.33% 162.48 18:23:45
Open Price Low Price High Price Close Price Prev Close
162.00 160.41 163.73 162.48 160.35
Trades Volume VWAP Dollar Volume Avg Volume
12,301 608,803  162.30  98,811,631 -
Last Trade Time Type Quantity Stock Price Currency
18:18:10 14  162.35 USD

Period:

Draw Mode:

BioNTech SE Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 39.43B 242.69M 242.69M  21.58B  11.97B 45.07 3.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.96% 06/02/22 - -

more financials information »

News BioNTech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

BNTX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Comirnaty (COVID-19 vaccine) is its first commercialized product.


Your Recent History
NASDAQ
BNTX
BioNTech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now